Answers are grounded in this paper and cite their sources.
Prospective multicentre study compares hospitalization impact of influenza and COVID-19 in Greece, indicating longer hospital stays for influenza patients.
AIM: To compare the burden and severe outcomes among patients hospitalised for influenza to those hospitalised for coronavirus disease 2019 (COVID-19) in Greece. METHODS: The study was conducted in four hospitals from November 2024 to May 2025. Main outcomes were length of stay (LOS) and severe outcomes (admission to intensive care unit, invasive mechanical ventilation, in-hospital death). The associations between LOS and adverse outcomes with COVID-19 or influenza were estimated with multivariable negative binomial and logistic regression models. Adjusted models yielded similar findings, with influenza patients having significantly longer LOS [incidence rate ratio (IRR): 1.47; 95% confidence interval (CI): 1.03-2.10] compared with COVID-19 patients, and no difference in the odds of experiencing any severe outcome [adjusted odds ratio (aOR) = 2.10; 95% CI: 0.88-5.04]. Pneumonia was associated with increased odds for any severe outcome (aOR: 7.55; 95% CI: 1.10-52.33) and longer LOS (IRR: 2.09; 95% CI: 1.39-3.15) overall and within diagnostic subgroups. Among COVID-19 patients, those with ≥1 COVID-19 vaccine dose had reduced odds for experiencing any severe outcome (aOR = 0.38; 95% CI: 0.15-0.96) compared with unvaccinated patients. CONCLUSIONS: In 2024-2025, influenza patients had significantly longer LOS than COVID-19 patients, while severe outcomes were not significantly different between the two groups.
No takes yet. Share an insight, caveat, or question.
Maltezou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: